Beta-agonists.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12428542.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Beta-Agonists are a mainstay of asthma treatment. Short-acting beta-agonists are the most effective bronchodilators for rescue or quick relief of symptoms. Long-acting beta-agonists have a key role in long-term control when added to inhaled corticosteroid therapy, and are especially useful in the control of nocturnal asthma. Both types of beta-agonists may be used in the prophylaxis of exercise-induced asthma with long-acting beta-agonists providing more prolonged protection. beta-Agonists have minimal side effects and are safe when used appropriately.
Medical subject headings
- Adrenergic beta-Agonists
- Asthma